The U.S. Food and Drug Administration (FDA) is currently accepting public comments on whether cannabis should be reclassified under global drug treaties.
The request, posted Oct. 10, asks for comments on abuse potential, actual abuse, medical usefulness, trafficking and the impact of scheduling changes on availability for medical use for marijuana and 15 other substances. The deadline for comment submission is Oct. 31.
The comments gathered will be considered as the United States prepares a response to the World Health Organization (WHO) regarding the abuse liability and diversion of cannabis and the other substances in question. WHO will then use the information as it explores the potential for loosening or lifting international restrictions on these drugs.
Comments can be submitted online or by mail, and will be accepted until 11:59 p.m. on Oct. 31.
Top Image: © sinhyu | Adobe Stock